Gregory A. Firestone - 03 Aug 2023 Form 3 Insider Report for TELA Bio, Inc. (TELA)

Role
Chief Business Officer
Signature
/s/ Megan Smeykal, Attorney-in-fact
Issuer symbol
TELA
Transactions as of
03 Aug 2023
Net transactions value
$0
Form type
3
Filing time
04 Aug 2023, 16:11:19 UTC
Next filing
07 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TELA Common Stock 14,961 03 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TELA Stock Option (Right to Buy) 03 Aug 2023 Common Stock 31,793 $5.93 Direct F1
holding TELA Stock Option (Right to Buy) 03 Aug 2023 Common Stock 2,308 $5.93 Direct F1
holding TELA Stock Option (Right to Buy) 03 Aug 2023 Common Stock 45,362 $13.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option are fully vested and exercisable.
F2 The option vested 25% on November 7, 2020, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney